Are you more inclined to use neoadjuvant endocrine therapy over neoadjuvant chemotherapy or upfront surgery for your ER+HER2- breast cancer patients during the COVID19 pandemic?

Personally, my practice is to guide patients directly to surgery or to do neoadjuvant chemotherapy rather than to do neoadjuvant endocrine therapy, but I can't guarantee medical services such as staging, OR time, or months of chemotherapy when the support staff are self-quarantining or staying home to care for their children because the schools and daycares are closed.